Uxbridge Animal Health Limited 11771551 true 2023-10-01 2024-09-30 2024-09-30 The principal activity of the company is that of a dormant company. Digita Accounts Production Advanced 6.30.9574.0 true Mrs A Doherty true 11771551 2023-10-01 2024-09-30 11771551 2024-09-30 11771551 core:ShareCapital 2024-09-30 11771551 core:CurrentFinancialInstruments 2024-09-30 11771551 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 11771551 bus:FRS102 2023-10-01 2024-09-30 11771551 bus:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 11771551 bus:FullAccounts 2023-10-01 2024-09-30 11771551 bus:RegisteredOffice 2023-10-01 2024-09-30 11771551 bus:Director1 2023-10-01 2024-09-30 11771551 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 11771551 core:ParentEntities 2023-10-01 2024-09-30 11771551 countries:EnglandWales 2023-10-01 2024-09-30 11771551 2022-10-01 2023-09-30 11771551 2023-09-30 11771551 core:ShareCapital 2023-09-30 11771551 core:CurrentFinancialInstruments 2023-09-30 11771551 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 iso4217:GBP xbrli:pure

Registration number: 11771551

Uxbridge Animal Health Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 September 2024

 

Uxbridge Animal Health Limited

Profit and Loss Account for the Year Ended 30 September 2024

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

Uxbridge Animal Health Limited

(Registration number: 11771551)
Balance Sheet as at 30 September 2024

Note

2024
£

2023
£

Current assets

 

Debtors

4

10

10

Capital and reserves

 

Called up share capital

10

10

Shareholders' funds

 

10

10

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 18 June 2025
 


Mrs A Doherty
Director

 

Uxbridge Animal Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
26-28 Pield Heath Road
Uxbridge
Middlesex
UB8 3NG

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Judgements

No significant judgements have been made by management in preparing these financial statements.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Uxbridge Animal Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2023 - 0).

 

4

Debtors

2024
£

2023
£

Other debtors

10

10

10

10

 

5

Related party transactions

Summary of transactions with parent

My Vet 24-7 Limited
 As at 30 September 2024, the company was owed £10 (2023: £10) from My Vet 24-7 Limited, its immediate parent company.
 

 

6

Parent and ultimate parent undertaking

The company is controlled by My Vet 24-7 Limited.

 The company's immediate parent is My Vet 24-7 Limited , incorporated in England and Wales .